Myriad Genetics stock forecast
Myriad Genetics (MYD) Stock Forecast & Price Target
MYD Analyst Ratings
MYD Stock 12 Month Forecast
Average Price Target
€5.13▼(-2.32% Downside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Mason Carrico | Stephens | €5.41 | hold | 2.95%Upside | Assigned | 11/12/26 | ||
| David Westenberg | Piper Sandler | €4.51 | hold | -14.21%Downside | Reiterated | 11/10/26 | ||
| Kyle Boucher | TD Cowen | €4.06→€6.08 | hold | 15.82%Upside | Assigned | 11/05/26 | ||
 Unknown AnalystNot Ranked | Leerink Partners | €4.51→€7.21 | hold | 37.27%Upside | Reiterated | 11/05/26 | ||
| Lu Li | Bank of America Securities | ― | sell | ― | Reiterated | 11/05/26 | ||
| William Bonello | Craig-Hallum | €7.21 | buy | 37.27%Upside | Reiterated | 10/21/26 | ||
| Unknown AnalystNot Ranked | UBS | €5.41→€3.24 | hold | -38.23%Downside | Initiated | 09/08/26 | ||
| Unknown AnalystNot Ranked | Jefferies | €2.25 | sell | -57.10%Downside | Reiterated | 08/21/26 | ||
| Unknown AnalystNot Ranked | Guggenheim | ― | hold | ― | Reiterated | 08/03/26 | ||
| Andrew Cooper | Raymond James | €5.88→€7.21 | buy | 37.27%Upside | Reiterated | 01/13/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Mason CarricoStephens | HoldAssigned€5.41 | 11/12/26 | 2.95%Upside | ||
| David WestenbergPiper Sandler | HoldReiterated€4.51 | 11/10/26 | -14.21%Downside | ||
| Kyle BoucherTD Cowen | HoldAssigned€4.06→€6.08 | 11/05/26 | 15.82%Upside | ||
| Unknown AnalystLeerink PartnersNot Ranked | HoldReiterated€4.51→€7.21 | 11/05/26 | 37.27%Upside | ||
| Lu LiBank of America Securities | SellReiterated | 11/05/26 | ― | ||
| William BonelloCraig-Hallum | BuyReiterated€7.21 | 10/21/26 | 37.27%Upside | ||
| Unknown AnalystUBSNot Ranked | HoldInitiated€5.41→€3.24 | 09/08/26 | -38.23%Downside | ||
| Unknown AnalystJefferiesNot Ranked | SellReiterated€2.25 | 08/21/26 | -57.10%Downside | ||
| Unknown AnalystGuggenheimNot Ranked | HoldReiterated | 08/03/26 | ― | ||
| Andrew CooperRaymond James | BuyReiterated€5.88→€7.21 | 01/13/26 | 37.27%Upside |
Best Analysts Covering Myriad Genetics
Copying Andrew Cooper's trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of -0.92% per trade.
Copying William Bonello's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of -3.51% per trade.
Copying William Bonello's trades and holding each position for 2 Years would result in 62.50% of your transactions generating a profit, with an average return of +9.89% per trade.
MYD Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 4 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 1 | 1 |
| Hold | 6 | 6 | 8 | 6 | 8 |
| Sell | 2 | 3 | 4 | 4 | 3 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 12 | 10 | 13 | 12 | 13 |
In the current month, MYD has received 2 Buy Ratings, 8 Hold Ratings, and 3 Sell Ratings. MYD average Analyst price target in the past 3 months is 5.13.
MYD Financial Forecast
MYD Earnings Forecast
Next quarter’s earnings estimate for MYD is -EUR 0.20 with a range of -EUR 0.30 to -EUR 0.11. The previous quarter’s EPS was -EUR 0.10. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
MYD Sales Forecast
Next quarter’s sales forecast for MYD is EUR 173.82M with a range of EUR 171.99M to EUR 176.63M. The previous quarter’s sales results were EUR 182.67M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
